1994
DOI: 10.1023/a:1018978602141
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: In aqueous solutions, dalvastatin (1) undergoes epimerization as well as hydrolysis. The transformation of the drug was studied as a function of pH at 25 degrees C in aqueous solutions containing 20% acetonitrile. At all pH values, first-order plots for the conversion are biphasic, indicating rapid equilibration of 1 with its epimer (2) and slower hydrolysis of 1 to the corresponding beta-hydroxy acid (3). Apparent first-order rate constants for the biexponential equation are given as a function of pH. The alk… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2006
2006
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 3 publications
0
5
0
Order By: Relevance
“…The enzymatic conversion from the hydroxy acid form to the lactone form is mediated by uridine 5 0diphospho-glucuronosyltransferases. The acid-base-mediated interconversions greatly favors the hydroxy acid form when pH > 6, and can be reversed when the pH is lower such as at pH 2; therefore, it is important to keep the ex vivo sample pH between 4 and 5 to maintain the interconversion at equilibrium (Jemal & Xia, 2000;Kearney et al, 1993;Won, 1994). While the conversion from rosuvastatin lactone to rosuvastatin in clinical samples can be controlled by acidifying the plasma samples (Cooper et al, 2003), the implementation of sample pre-treatment procedures during sample collection at the clinical site is often difficult to carry out, especially in late phase clinical trials.…”
Section: Benchtop Conversion Of Rosuvastatin Lactone To Rosuvastatin ...mentioning
confidence: 99%
See 1 more Smart Citation
“…The enzymatic conversion from the hydroxy acid form to the lactone form is mediated by uridine 5 0diphospho-glucuronosyltransferases. The acid-base-mediated interconversions greatly favors the hydroxy acid form when pH > 6, and can be reversed when the pH is lower such as at pH 2; therefore, it is important to keep the ex vivo sample pH between 4 and 5 to maintain the interconversion at equilibrium (Jemal & Xia, 2000;Kearney et al, 1993;Won, 1994). While the conversion from rosuvastatin lactone to rosuvastatin in clinical samples can be controlled by acidifying the plasma samples (Cooper et al, 2003), the implementation of sample pre-treatment procedures during sample collection at the clinical site is often difficult to carry out, especially in late phase clinical trials.…”
Section: Benchtop Conversion Of Rosuvastatin Lactone To Rosuvastatin ...mentioning
confidence: 99%
“…The extent of the conversion is dependent upon the pH, solvent composition and temperature (Kaufman, 1990;Kearney et al, 1993;Won, 1994;Yang & Hwang, 2006). Rosuvastatin is a synthetic statin.…”
mentioning
confidence: 99%
“…Minimizing interconversion will depend on conditions during the bio-analytical procedure, pH being one of the most important factors, together with temperature. Other reasons for sample instability could be epimerization [120,121] or E to Z isomerisation reactions [122,123], influenced again by pH or light exposure.…”
Section: Stability Of Biological Samplesmentioning
confidence: 99%
“…One of the challenges faced in plasma sample collection, storage, and extraction is the instability of drugs, *Address correspondence to this author at Bristol-Myers Squibb, Bioanalytical and Discovery Analytical Sciences, Route 206 and Province Line Road, Princeton, NJ 08543, USA; Tel: 609-252-3572; Fax: 609-252-7825; E-mail: mohammed.jemal@bms.com metabolites and prodrugs in biological samples. Compound stability in plasma may be affected by enzymes and/or pH of the biological samples, anticoagulants, storage temperature and freeze-thaw cycles [12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28]. While the degradation of a drug during sample collection and storage causes underestimation of the drug concentration, the degradation of the metabolite or prodrug may cause over-estimation of the drug concentration.…”
Section: Plasma Collection and Storagementioning
confidence: 99%
“…Epimerization is another potential cause for sample instability [21,22]. A sample that contains a thiol drug and its disulfide metabolite may also cause an analytical challenge due to the potential for the conversion of the thiol to the disulfide or vice versa [23].…”
Section: Plasma Collection and Storagementioning
confidence: 99%